 |
Reversing Cancer and Ageing: Multiple Personal Genomes, Life Complexity and Myriad Clinical Challenges |
|
|
|
83 - 87 |
10.2122/gbc.2010.0127 |
|
Cetuximab, panitumumab and bevacizumab resistance in colorectal cancer: Are molecular networks the solution? |
|
|
|
88 - 94 |
10.2122/gbc.2010.0129 |
|
Comparative-effectiveness research and personalized medicine: Trends and debate |
|
|
|
95 - 101 |
10.2122/gbc.2010.0130 |
|
Evidence-based laparoscopic surgery for low rectal cancer |
|
|
|
102-105 |
10.2122/gbc.2010.0131 |
|
Trastuzumab for small HER2-positive breast cancer? Uncertainty and new research directions |
|
|
|
106-109 |
10.2122/gbc.2010.0132 |
|
Intellectual innovation and new technology in surgical oncology |
|
|
|
110-112 |
10.2122/gbc.2010.0133 |
|
Western challenges with esophagectomy and follow-up |
|
|
|
113-115 |
10.2122/gbc.2010.0134 |
|
Standardizing colorectal cancer treatment
|
|
|
|
116-118 |
10.2122/gbc.2010.0135 |
|
Selection and identification of DNA aptamers to gastric cancer cell SGC-7901
|
|
|
|
119-126 |
10.2122/gbc.2010.0128 |
